SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Küppers R, Rajewsky K. The origin of Hodgkin and Reed Sternberg cells in Hodgkin's disease. Annu Rev Immunol 1998;16: 47193.
  • 2
    Marafioti T, Hummel M, Foss HD, Laumen H, Korbjuhn P, Anagnostopoulos I, Lammert H, Demel G, Theil J, Wirth T, Stein H. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 2000;95: 144350.
  • 3
    Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12: 1217.
  • 4
    Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol 2001;2: 95101.
  • 5
    Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2: 10815.
  • 6
    Poppema S, Potters M, Visser L, Van den Berg A. Immune escape mechanisms in Hodgkin's disease. Ann Oncol 1998;9 (Suppl 5): 214.
  • 7
    Poppema S, Potters M, Emmens R, Visser L, Van den Berg A. Immune reactions in classical HL. Semin Hematol 1999;36: 2539.
  • 8
    Van den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am J Pathol 1999;154: 168591.
  • 9
    Beck A, Pazolt D, Grabenbauer GG, Nicholls JM, Herbst H, Young LS, Niedobitek G. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease. J Pathol 2001;194: 14551.
  • 10
    Peh SC, Kim LH, Poppema S. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP's Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am J Surg Pathol 2001;25: 9259.
  • 11
    Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997;272: 1503642.
  • 12
    Tedla N, Paladinetti P, Wakefield D, Lloyd A. Abundant expression of chemokines in malignant and infective human lymphadenopathies. Cytokine 1999;11: 53140.
  • 13
    Teruya-Feldstein J, Jaffe ES, Burd PR, Kingma DW, Setsuda JE, Tosato G. Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 1999;93: 246370.
  • 14
    Teruya-Feldstein J, Tosato G, Jaffe ES. The role of chemokines in Hodgkin's disease. Leuk Lymphoma 2000;38: 36371.
  • 15
    Hedvat CV, Jaffe ES, Qin J, Filippa DA, Cordon-Cardo C, Tosato G, Nimer SD, Teruya-Feldstein J. Macrophage derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays. Mod Pathol 2001;14: 12706.
  • 16
    Gruss HJ, Brach MA, Drexler H-G, Bonifer R, Mertelsmann RH, Herrmann F. Expression of cytokine genes, cytokine receptor genes and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Cancer Res 1992;52: 335360.
  • 17
    Bargou RC, Mapara MY, Zugek C, Daniel PT, Pawlita M, Dohner H, Dorken B. Characterization of a novel Hodgkin cell line, HD-myZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice. J Exp Med 1993;177: 125768.
  • 18
    Drexler G. 1993. Recent results on biology of Hodgkin and Reed-Sternberg cells II. Continuous cell lines. Leuk Lymphoma 1993;9: 125.
  • 19
    Tesch H, Gorschlüter M, Hasnclever D, Bohlen H, Diehl V. Correlations of cytokine levels with clinical parameters in patients with Hodgkin's disease [abstract]. Ann Hematol 1993;67S: 124a.
  • 20
    Trümper L, Jung W, dahl G, Diehl V, Gause A, Pfreundschuh M. Interleukin 7, Interleukin 8, soluble TNF receptor, and p53 protein levels are elevated in serum of patients with Hodgkin's disease. Ann Oncol 1994;5: S936.
  • 21
    Foss HD, Herbst H, Gottstein S, Demel G, Araujo I, Stein H. Interleukin-8 in Hodgkin's disease: preferential expression by reactive cells and association with neutrophil density. Am J Pathol 1996;148: 122936.
  • 22
    Luciani MG, Stroppacciaro A, Peri G, Mantovani L, Ruco LP. The monocyte chemotactic protein 1 (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumors. J Clin Pathol 1998;51: 2736.
  • 23
    Jundt F, Anagnostopoulos I, Bommert K, Emmerich F, Muller G, Foss HD, Royer HD, Stein H, Dorken B. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T-cells and eosinophils. Blood 1999;94: 206571.
  • 24
    Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heintz F, Sueno K. Characteristics of Hodgkin's disease derived cell lines. Cancer Treat Rep 1982;66: 61532.
  • 25
    Kanzler H, Hansmann ML, Kapp U, Wolf J, Diehl V, Rajewsky K, Kuppers R. Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. Blood 1996;87: 342936.
  • 26
    Poppema S, De Jong B, Atmosoerodjo J, Idenburg V, Visser L, De Ley L. Morphologic, immunologic, enzyme histochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Reed-Sternberg cells. Cancer 1985;15: 68390.
  • 27
    Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FG, Karpas A. A Ki-1 (CD30)-positive human cell line (Karpas299) established from a high grade non-Hodgkin's lymphoma, showing a 2; 5 translocation and rearrangements of the T-cell receptor b-chain gene. Blood 1988;72: 23440.
  • 28
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. 1999. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999;10: 141932.
  • 29
    Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dorken B. High level nuclear NF-kappaB and Oct2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996;87: 43407.
  • 30
    Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B. Constitutive nuclear NF-kappaB-Rel A activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100: 29619.
  • 31
    Toruma K, Narumi S. Differential induction of interferon (IFN)-inducible protein 10 following differentiation of a monocyte, macrophage cell lineage is related to the changes of nuclear proteins bound to IFN stimulus response element and KappaB sites. Int J Mol Med 1999;3: 47784.
  • 32
    Lee AH, Hong JH, Seo YS. Tumor necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J 2000;1: 1318.
  • 33
    Huen DS, Henderson SA, Croom-Carter D, Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappaB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995;10: 54960.
  • 34
    Sylla BS, Hung SC, Davidson DM, Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E, Mosialos G. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. Proc Natl Acad Sci USA 1998;95: 1010611.
  • 35
    Liao F, Rabin R, Yannelli J, Koniaris L, Vanguri P, Farber J. Human Mig chemokine: biochemical and functional characterization. J Exp Med 1995;182: 130114.
  • 36
    Teruya-Feldstein J, Jaffe ES, Burd PR, Kanegane H, Kingma DW, Wilson WH, Longo DL, Tosato G. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997;90: 4099105.
  • 37
    Hsu S, Waldron JW, Hsu P, Hough J. Cytokine in malignant lymphomas: review and prospective evaluation. Hum Pathol 1993;24: 104057.
  • 38
    Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B cell homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998;19: 799803.
  • 39
    Hjelmström P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 2001;69: 3319.
  • 40
    Miller MD, Krangel MS. The human cytokine I-309 is a monocyte chemoattractant. Proc Natl Acad Sci USA 1992;89: 29504.
  • 41
    Inngjerdingen M, Damaj B, Maghazachi AA. Human NK cells express chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage derived chemokine, and I-309. J Immunol 2000;164: 404854.
  • 42
    Schall TJ, Bacon K, Toy KL, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347: 66971.
  • 43
    Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176: 148995.
  • 44
    Buri C, Körner M, Schärli P, Cefai D, Uguccioni M, Mueller C, Laissue JA, Mazzucchelli L. CC chemokines and receptors CCR3 and CCR5 are differentially expressed in nonneoplastic leukocytic infiltrates of Hodgkin disease. Blood 2001;97: 15438.
  • 45
    Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277: 20057.
  • 46
    Garcia-Zepeda EA, Combadiere C, Rothenberg ME, Sarafi MN, Lavigne F, Hamid Q, Murphy PM, Luster AD. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996;157: 561326.
  • 47
    Yoshida R, Nagira M, Imai T, Baba M, Takagi S, Tabira Y, Akagi J, Nomiyama H, Yoshie O. Ebl1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC. Int Immunol 1998;10: 90110.
  • 48
    Sallusto F, Lanzavecchia A. Understanding dendritic cell and T-lymphocyte through the analysis of chemokine receptor expression. Immunol Rev 2000;177: 13440.
  • 49
    Schutyser E, Struyf S, Menten P, Lenaerts JP, Conings R, Put W, Wuyts A, Proost P, Van Damme J. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells. J Immunol 2000;165: 44707.
  • 50
    Willimann K, Legler DF, Loetscher M, Roos RS, Delgado MB, Clark-Lewis I, Baggiolini M, Moser B. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol 1998;28: 202534.
  • 51
    Godiska R, Chantry D., Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, Gray PW. Human macrophage derived chemokine (MDC): a novel chemoattractant for monocytes, monocyte derived dendritic cells and natural killer cells. J Exp Med 1997;185: 1595604.
  • 52
    Mantovani A, Gray PA, Van Damme J, Sozzani S. Macrophage derived chemokine. J Leukoc Biol 2000;68: 4004.
  • 53
    Vulcano M, Albanesi C, Stoppacciaro A, Bagnati R, D'Amico G, Struyf S, Transidico P, Bonecchi R, Del Prete A, Allavena P, Ruco LP, Chiabrando C, et al. Dendritic cells as a major source of macrophage derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 2001;31: 81222.
  • 54
    Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, Yoshie O, Gray PW. Macrophage derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998;273: 17648.
  • 55
    Andrew DP, Chang M, McNinch J, Wathen ST, Rihanek M, Tseng J, Spellberg JP, Elias CG 3rd. STCP-1 (MDC) CC chemokine acts specifically on chronically activated TH2 lymphocytes and is produced by monocytes on stimulation with TH2 cytokines IL-4 and IL-13. J Immunol 1998;161: 502738.
  • 56
    Bonecchi R, Sozzani S, Stine JT, Luini W, D'Amico G, Allavena P, Chantry D, Mantovani A. Divergent effects of interleukin-4 and interferon-gamma on macrophage derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 1998;92: 266871.
  • 57
    Hsu S, Hsu P. Lack of effect of colony stimulating factors, interleukins, interferons and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells: comparison with effects of phorbol ester and retinoic acid. Am J Pathol 1996;136: 1819.
  • 58
    Cossmann J, Annunziata CM, Barash S, Staudt L, Dillon P, He WW, Ricciardi-Castagnoli P, Rosen CA, Carter KC. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 1999;94: 4116.
  • 59
    Proost P, De Meester I, Schols D, Struyf S, Lambeir AM, Wuyts A, Opdenakker G, De Clercq E, Scharpe S, Van Damme J. 1998. Amino-terminal truncation of chemokines by Cd26/dipeptidyl-peptidase IV. J Biol Chem 1998;273: 72227.
  • 60
    Van Damme J, Struyf S, Wuyts A, Van Coillie E, Menten P, Schols D, Sozzani S, De Meester I, Proost P. 1999. The role of CD26/DPP IV in chemokine processing. Chem Immunol 1999;72: 4256.
  • 61
    Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, Nguyen NY, Boykins R, Unsworth E, Norcross MA. 1997. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 1997;186: 186572.
  • 62
    Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, Lenaerts JP, Detheux M, Parmentier M, De Meester I, Scharpe S, Van Damme J. 1999. CD26/dipeptidyl-peptidase down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 1999;162: 49039.
  • 63
    Fleischer B. CD 26: a surface protease involved in T-cell activation. Immunol Today 1994;15: 1804.
  • 64
    Poppema S. Immunology of Hodgkin's disease. Baillieres Clin Haematol 1996;9: 44757.